Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Zeitschrift Fur Naturforschung. C, Journal of Biosciences|May 29, 2024
Navigating the landscape of theranostics in nuclear medicine: current practice and future prospectsAayushi Shah, Akshada Dabhade, Hetvi Bharadia, et al.
Critical Reviews in Oncology/Hematology|August 3, 2023
Combating relapsed and refractory Mantle cell lymphoma with novel therapeutic armamentarium: Recent advances and clinical prospectsNeha R Raghani, Disha D Shah, Tithi S Shah, et al.
Archives of Virology|September 14, 2023
Molnupiravir: an antiviral drug against COVID-19Bhavarth Dave, Kashvi C Shah, Mehul R Chorawala, et al.
Current Diabetes Reviews|August 13, 2024
The Role of Dietary Anthocyanins for Managing Diabetes Mellitus-Associated ComplicationsPriya S Mistry, Mehul R Chorawala, Bhagavathi Sundaram Sivamaruthi, et al.
Zeitschrift Fur Naturforschung. C, Journal of Biosciences|May 27, 2025
From current landscape to future horizon in stem cell therapy for tissue regeneration and wound healing: bridging the gapKashvy R Morakhia, Aayushi C Shah, Mannat P Patel, et al.
Medical Oncology (Northwood, London, England)|June 27, 2025
Harnessing the immune responses: a new frontier in Ewing sarcoma treatmentDiya S Patel, Riddhi T Desai, Aanshi J Pandya, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|May 13, 2025
Therapeutic potential of stem cells in colorectal cancer management: Current trends and future prospectsManya D Desai, Namrata B Parmar, Isha T Shah, et al.
Medical Oncology (Northwood, London, England)|January 9, 2024
Revolutionizing cancer treatment: comprehensive insights into immunotherapeutic strategiesNeha R Raghani, Mehul R Chorawala, Mayuresh Mahadik, et al.
Medical Oncology (Northwood, London, England)|August 6, 2025
CAR T-cell immunotherapy as the next horizon in cancer eradication: current landscape, challenges, and future directionsHetvi Bharadia, Akshada Dabhade, Aayushi C Shah, et al.
Biopharmaceutics & Drug Disposition|March 7, 2013
In vivo performance evaluation and establishment of IVIVC for osmotic pump based extended release formulation of milnacipran HClPunit B Parejiya, Bhavesh S Barot, Hetal K Patel, et al.
Pageof 5